Research to Establish the Validity, Reliability, and Clinical Utility of a Comprehensive Language Assessment of Mandarin.

Purpose: With no existing gold standard for comparison, challenges arise for establishing the validity of a new standardized Mandarin language assessment normed in mainland China. Method: A new assessment, Diagnostic Receptive and Expressive Assessment of Mandarin (DREAM), was normed with a stratifi...

Full description

Bibliographic Details
Published in:Journal of Speech, Language & Hearing Research Vol. 60; no. 3; pp. 592 - 607
Main Authors: Liu, Xueman Lucy, de Villiers, Jill, Chunyan Ning, Rolfhus, Eric, Hutchings, Teresa, Lee, Wendy, Jiang, Fan, Yi Wen Zhang
Format: Article
Published: American Speech-Language-Hearing Association Mar2017
Subjects:
Online Access:View this record in EBSCOhost
Description
Summary:Purpose: With no existing gold standard for comparison, challenges arise for establishing the validity of a new standardized Mandarin language assessment normed in mainland China. Method: A new assessment, Diagnostic Receptive and Expressive Assessment of Mandarin (DREAM), was normed with a stratified sample of 969 children ages 2;6 (years; months) to 7;11 in multiple urban and nonurban regions in northern and southern China. In this study of 230 children, the sensitivity and specificity of DREAM were examined against an a priori judgment of disorders. External validity was assessed using 2 indices of language production for different age groups. Results: External validity was assessed against spontaneous language indices (correlation range: r = .6-.7; allps < .01) and narrative indices (overall: r = .45, p < .01). Sensitivity (.73) and specificity (.82) of DREAM are moderate to good using a priori judgment as the standard. The values improved to .95 and .82 when spontaneous language and narratives were added to a priori judgment to define typicality. Divergent validity was moderate with nonlinguistic indices. Conclusion: DREAM holds promise as a diagnostic test of Mandarin language impairment for children aged 2;6 to7;11.